Afuco™ Anti-Human FLT4 ADCC Theraputic Antibody (IMC-3C5), ADCC Enhanced
Product Quick Detail
- Place Of Origin
- USA
- Minimum Order
- 1
- Packaging
- N/A
- Delivery
- 15 Days
Specifications
Anti-FLT4 ADCC Enhanced Antibody (IMC-3C5) is an ADCC enhanced antibody produced by our Afuco™ platform. IMC-3C5 is a human IgG1 monoclonal antibody receptor antagonist designed to bind VEGFR3
and block the binding of VEGF-C and VEGF-D ligands to the receptor, used to treat solid tumors.
https://www.creativebiolabs.net/Anti-FLT4-ADCC-Enhanced-Antibody-IMC-3C5-20585.htm
- Country: United States
- Founded Year: 2005
- Contact: Jerry Carter
